Susan Hasty, Publisher
Table of Contents . . . November 5th, 2002
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Cancer Weekly | Other Publications
Gene Cleaving - DNAzymes act as cancer fighting agents
Liver Cancer - Das-1 immunostain distinguishes some classes of liver tumors from others
Breast Cancer - OSU studies risk related to beef consumption
Gastric Cancer - Cytokine may play role in gastric carcinoma angiogenesis
Head and Neck Cancer - P53 suppressor gene studied
Hodgkin Disease - IMRT promising for treatment with minimal side effects
Kaposi Sarcoma - Genetic findings in monkey herpes virus could aid research in human cancer
Lung Cancer - Conventional CT models not adequate for modeling lung tumors during breathing
Appointments - Cancer treatment developer names CFO, strengthens board of directors
Appointments - Judy H. Chiao, MD, named VP, oncology clinical R&D of drug discovery company
Brain Cancer - DTI-015 developer completes enrollment of phase I/II trial of the new drug
Breast Cancer - Avon Foundation awards $2.785M grant for research and education
Breast Cancer - Brachytherapy is an effective treatment
Breast Cancer - FDA approves inclusion of gene test in Herceptin labeling
Breast Cancer - Lumpectomy just as effective as mastectomy
Breast Cancer - Medical advice to women contradictory, confusing
Breast Cancer - Plant-based estrogens and genetic variations in their breakdown to be studied
Breast Cancer - Postmastectomy radiation reduces the risk of recurrence
Cancer Therapy - Alfacell, NCI expand research collaboration
Cancer Therapy - Company to challenge FDA delay of manufactured tamoxifen launch
Cancer Therapy - Investigational new drug applications filed for M-Vax, O-Vax
Cancer Therapy - One day, nanotechnology could be used to track and kill cancer cells
Cancer Therapy - Team challenges nature of phase I trials for evaluating antiangiogenic therapy
Cancer Therapy - Zentaris inks agreement with oncology-focused company for oral signal transduction modulator
Cellular Imaging - Automated imaging company releases new clinical system
Cervical Cancer - Combining chemotherapy, radiation therapy improves survival odds
Cervical Cancer - New treatment for sexual dysfunction
Cervical Cancer - Women with advanced disease need varied therapy, study shows
Colorectal Cancer - Data reported from preclinical DACH platinum study in mice
Drug Delivery - Vitamin-mediated tumor targeting data confirm enhanced drug uptake
Drug Discovery - CRO announces services agreement with MedImmune
Electrosurgical Technology - Controlled tissue resection system minimizes collateral tissue damage
Glioma - Company licenses TransMID product to Nycomed
Head and Neck Cancer - High-risk tumors largely resist chemotherapy attack
Lung Cancer - European trial finds old lung cancer treatment may still be best
Melanoma - Combination of gene-loaded vectors suppresses human skin cancer
Melanoma - Study finds declines in 20- to 44-year-olds
Mortality - Cancer survival rates higher than previously assumed
Neuroendocrine Tumors - FDA awards EntreMed orphan drug grant for Endostatin trial
Non-Hodgkin Lymphoma - Combining ionizing radiation and radioimmunotherapy appears safe
Non-Small Cell Lung Cancer - Company updates RSR13 phase II study results
Ovarian Cancer - Patient recruitment target reached in pivotal trial of pemtumomab
Prostate Cancer - Phase III clinical results for 4-month product reported
Radiation Therapy - Spice may protect skin during treatment for cancer
Rectal Cancer - Looking at sphincter preservation and quality of life
Restructuring - Company restructures AxCell subsidiary to support oncology focus
Thyroid Cancer - Researchers find promising preliminary results from gene therapy
Women's Health - HPV16 antibodies cause regression of cervical neoplasia
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.